Phase II study of oxaliplatin and fluorouracil in taxane- and anthracycline-pretreated breast cancer patients.
Zelek L, Cottu P, Tubiana-Hulin M, Vannetzel JM, Chollet P, Misset JL, Chouaki N, Marty M, Gamelin E, Culine S, Dieras V, Mackenzie S, Spielmann M.
Zelek L, et al. Among authors: misset jl.
J Clin Oncol. 2002 May 15;20(10):2551-8. doi: 10.1200/JCO.2002.06.164.
J Clin Oncol. 2002.
PMID: 12011135
Clinical Trial.